Posted by Gary Schwitzer in Consumer anger/confusion, Shared decision-making
Dr. Kenny Lin writes on his Common Sense Family Doctor blog about “The reality behind ‘death panel’ rhetoric.” It’s based on an “On Being a Doctor” column in the Annals of Internal Medicine.
It’s an important perspective. Please read.
Comments are closed.
It’s difficult to do an overview of melanoma drug research in a relatively brief story. But this story did a solid job.
Better than a competing piece by Reuters but still a little short on some details about this asthma drug study.
An adequate summary of this asthma drug trial’s design doesn’t make up for the overly optimistic tone about the drug’s future. A New York Times story was better.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2013 Health News Review
